David Smith

Q: What Schools Are Affiliated With David Smith

David Smith is affiliated with the following schools: University of California, Berkeley, University of Oxford, Stanford University, University of California, San Francisco, University of Southampton

David Smith's AcademicInfluence.com Rankings

David Smith

Medical

#933

World Rank

#1202

Historical Rank

Pharmacology

#63

World Rank

#84

Historical Rank

medical Degrees

Download Badge

Medical

David Smith's Degrees

PhD Pharmacology University of California, San Francisco
Bachelors Biochemistry University of California, Berkeley

Why Is David Smith Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David Smith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) (1644)
The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. (1984) (1581)
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. (1998) (1448)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) (1441)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) (1388)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones (1990) (1063)
Facts and recommendations about total homocysteine determinations: an expert opinion. (2004) (1020)
The neuropsychology of schizophrenia (1991) (1001)
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines (1984) (868)
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material (1984) (713)
Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial (2010) (680)
Is folic acid good for everyone? (2008) (589)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2010) (587)
An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat (1985) (546)
Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy (1995) (527)
Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic Stimulation (1967) (500)
The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. (2006) (488)
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease (1999) (487)
Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy (1984) (469)
Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the golgi‐peroxidase transport‐degeneration procedure (1981) (462)
Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment (2013) (442)
Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial (2012) (391)
A simple method for the isolation of adrenal chromaffin granules on a large scale. (1967) (381)
Cell cycle markers in the hippocampus in Alzheimer’s disease (1997) (323)
Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium‐size spiny neurons in the rat neostriatum (1988) (321)
An approach to tracing neuron networks in the cerebral cortex and basal ganglia. Combination of golgi staining, retrograde transport of horseradish peroxidase and anterograde degeneration of synaptic boutons in the same material (1979) (312)
Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. (1967) (306)
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. (1995) (305)
Homocysteine, B Vitamins, and Cognitive Impairment. (2016) (305)
Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease (2011) (292)
Glutamate decarboxylase‐immunoreactive terminals of Golgi‐impregnated axoaxonic cells and of presumed basket cells in synaptic contact with pyramidal neurons of the cat's visual cortex (1983) (292)
Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. (1989) (275)
Substance P-Containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat (1986) (268)
Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine (1991) (263)
A new type of specific interneuron in the monkey hippocampus forming synapses exclusively with the axon initial segments of pyramidal cells (1983) (247)
Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. (2009) (245)
The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease (1997) (238)
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease (1995) (238)
Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions (1997) (228)
Glutamate decarboxylase‐immunoreactive structures in the rat neostriatum: A correlated light and electron microscopic study including a combination of Golgi impregnation with immunocytochemistry (1985) (227)
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease (1994) (225)
Fundamental Mechanisms in the Release of Catecholamines (1972) (219)
Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. (1997) (217)
Monosynaptic input from the nucleus accumbens-ventral striatum region to retrogradely labelled nigrostriatal neurones (1981) (216)
Cholinergic synapses in the rat brain: a correlated light and electron microscopic immunohistochemical study employing a monoclonal antibody against choline acetyltransferase (1984) (216)
Glutamate decarboxylase immunoreactivity in the hippocampus of the cat: distribution of immunoreactive synaptic terminals with special reference to the axon initial segment of pyramidal neurons (1983) (216)
The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine? (2008) (216)
A type of aspiny neuron in the rat neostriatum accumulates [3H]γ‐aminobutyric acid: Combination of golgi‐staining, autoradiography, and electron microscopy (1983) (211)
Secretion from the adrenal medulla: biochemical evidence for exocytosis. (1967) (209)
Projection of neostriatal spiny neurons to the substantia nigra. Application of a combined golgi-staining and horse-radish peroxidase transport procedure at both light and electron microscopic levels (1979) (205)
Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. (2005) (205)
Individual differences in locomotor activity and sensitization (1991) (204)
Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis (1973) (199)
Localization of substance P-like immunoreactivity in neurons and nerve terminals in the neostriatum of the rat: a correlated light and electron microscopic study (1983) (195)
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease. (2002) (192)
Amygdala input to medial prefrontal cortex (mPFC) in the rat: A light and electron microscope study (1996) (187)
Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. (1998) (187)
Imaging the progression of Alzheimer pathology through the brain (2002) (185)
Coexistence of GABA and glutamate in mossy fiber terminals of the primate hippocampus: An ultrastructural study (1991) (185)
Homocysteine and Dementia: An International Consensus Statement1 (2018) (184)
AMNIOTIC-FLUID ACETYLCHOLINESTERASE AS A POSSIBLE DIAGNOSTIC TEST FOR NEURAL-TUBE DEFECTS IN EARLY PREGNANCY (1979) (175)
Release of dopamine beta-hydroxylase and chromogranin A upon stimulation of the splenic nerve. (1970) (174)
Vitamin B12 status and rate of brain volume loss in community-dwelling elderly (2008) (173)
Low free testosterone is an independent risk factor for Alzheimer's disease (2004) (172)
Serum total testosterone is lower in men with Alzheimer's disease. (2001) (171)
The cell division cycle and the pathophysiology of Alzheimer's disease. (1998) (171)
Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. (2000) (164)
Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study (2005) (162)
Preganglionic sympathetic neurones innervating the rat adrenal medulla: immunocytochemical evidence of synaptic input from nerve terminals containing substance P, GABA or 5-hydroxytryptamine. (1988) (160)
Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. (2002) (159)
The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine (1994) (150)
Dietary sources of vitamin B-12 and their association with plasma vitamin B-12 concentrations in the general population: the Hordaland Homocysteine Study. (2009) (150)
Fine structural studies on a type of somatostatin‐immurioreactive neuron and its synaptic connections in the rat neostriatum: A correlated light and electron microscopic study (1983) (150)
Cholecystokinin‐immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus (1985) (146)
Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. (2007) (145)
Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis (2010) (145)
The section-Golgi impregnation procedure. 2. Immunocytochemical demonstration of glutamate decar☐ylase in Golgi-impregnated neurons and in their afferent synaptic boutons in the visual cortex of the cat (1983) (144)
Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. (2015) (141)
Lipids of the adrenal medulla. Lysolecithin, a characteristic constituent of chromaffin granules. (1967) (138)
Synaptic Connections Between Spiny Neurons of the Direct and Indirect Pathways in the Neostriatum of the Rat: Evidence from Dopamine Receptor and Neuropeptide Immunostaining (1996) (136)
MECHANISMS INVOLVED IN THE RELEASE OF NORADRENALINE FROM SYMPATHETIC NERVES (1973) (136)
Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase (2011) (135)
Quantitative microdialysis of dopamine in the striatum: effect of circadian variation (1992) (134)
GABA‐immunoreactive synaptic boutons in the rat basal forebrain: Comparison of neurons that project to the neocortex with pallidosubthalamic neurons (1988) (134)
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease (2004) (133)
Monosynaptic projections from the rostral ventrolateral medulla oblongata to identified sympathetic preganglionic neurons (1993) (132)
Total Plasma Homocysteine, Age, Systolic Blood Pressure, and Cognitive Performance in Older People (2002) (132)
Synaptic organization of gabaergic inputs from the striatum and the globus pallidus onto neurons in the substantia nigra and retrorubral field which project to the medullary reticular formation (1992) (129)
LINOLEIC ACID AS AN IMMUNOSUPPRESSIVE AGENT (1975) (128)
Subcellular fractionation of splenic nerve: ATP, chromogranin A and dopamine beta-hydroxylase in noradrenergic vesicles. (1970) (127)
Epistasis in sporadic Alzheimer's disease (2009) (126)
A correlated light and electron microscopic study of identified cholinergic basal forebrain neurons that project to the cortex in the rat (1985) (125)
Synaptic connections of enkephalin-immunoreactive nerve terminals in the neostriatum: a correlated light and electron microscopic study (1982) (124)
Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review. (2018) (123)
Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. (2002) (122)
Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort (2012) (120)
Ultrastructural evidence of dopaminergic input to enkephalinergic neurons in rat neostriatum (1986) (120)
Membranes of the adrenal medulla. Behaviour of insoluble proteins of chromaffin granules on gel electrophoresis. (1970) (119)
Plasma vitamin B12 status and cerebral white-matter lesions (2008) (119)
Homocysteine as a predictor of cognitive decline in Alzheimer's disease (2009) (118)
Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer’s disease (2004) (118)
The section-Golgi-impregnation procedure—3. Combination of Golgi-impregnation with enzyme histochemistry and electron microscopy to characterize acetylcholinesterase-containing neurons in the rat neostriatum (1984) (118)
Vitamin B-12 and cognition in the elderly. (2009) (117)
A second type of striatonigral neuron: a comparison between retrogradely labelled and golgi-stained neurons at the light and electron microscopic levels (1981) (116)
Estrous cycle effects on operant responding for ethanol in female rats. (1998) (112)
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology (2001) (111)
Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats. (1999) (111)
Summing up: some implications of the neuron as a secreting cell. (1971) (109)
Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. (2009) (108)
Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease (2009) (103)
Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19 (2020) (102)
Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment (2016) (101)
Testosterone and gonadotropin levels in men with dementia. (2003) (101)
The synergy factor: a statistic to measure interactions in complex diseases (2009) (99)
The in vivo microdialysis recovery of dopamine is altered independently of basal level by 6-hydroxydopamine lesions to the nucleus accumbens (1991) (99)
Rate of progression of cognitive decline in Alzheimer’s disease: effect of butyrylcholinesterase K gene variation (2005) (98)
A monosynaptic pathway from an identified vasomotor centre in the medial prefrontal cortex to an autonomic area in the thoracic spinal cord (1993) (97)
Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. (1996) (96)
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer’s disease (2005) (96)
The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat (1996) (95)
Plasma Total Homocysteine and Cognitive Performance in a Volunteer Elderly Population (2000) (94)
Subcellular localisation of noradrenaline in sympathetic neurons. (1972) (90)
Placental anatomy and diffusing capacity in guinea pigs following long-term maternal hypoxia. (1984) (87)
Use of structural imaging to study the progression of Alzheimer's disease. (1996) (86)
Sulfur amino acids in methionine-restricted rats: hyperhomocysteinemia. (2010) (86)
Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. (2007) (85)
The vitamin D receptor gene is associated with Alzheimer's disease (2011) (85)
The association between depression, anxiety, and cognitive function in the elderly general population—the Hordaland Health Study (2005) (84)
Kynurenine Pathway Metabolites in Alzheimer's Disease. (2017) (84)
Plasma folate concentration and cognitive performance: Rotterdam Scan Study. (2007) (82)
Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study (2010) (82)
Effect of carbon dioxide concentration on calcification in the red coralline alga Bossiella orbigniana (1979) (82)
Negative symptoms in schizophrenia: assessment of the effect of risperidone. (1994) (81)
Prevalence of dementia in a semi‐urban population in Sri Lanka: report from a regional survey (2003) (81)
Evidence for the release of vesicle-proteins together with noradrenaline upon stimulation of the splenic nerve. (1969) (81)
Cysteine and obesity: consistency of the evidence across epidemiologic, animal and cellular studies (2012) (80)
The proportion of neurons in the rat neostriatum that project to the substantia nigra demonstrated using horseradish peroxidase conjugated with wheatgerm agglutinin (1981) (79)
Low vitamin B-12 status in confirmed Alzheimer’s disease as revealed by serum holotranscobalamin (2003) (78)
Incubation of exogenous fatty acids with lymphocytes. Changes in fatty acid composition and effects on the rotational relaxation time of 1,6-diphenyl-1,3,5-hexatriene. (1980) (77)
GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin-peroxidase and protein A-colloidal gold (1985) (77)
Descending Projections from the Substantia Nigra and Retrorubral Field to the Medullary and Pontomedullary Reticular Formation (1991) (76)
Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis (1970) (76)
Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease (2009) (75)
The localization of lysosomal enzymes in chromaffin tissue (1966) (75)
Cholecystokinin-immunoreactive boutons in synaptic contact with hippocampal pyramidal neurons that project to the nucleus accumbens (1986) (72)
Association of Vitamin B12, Folate, and Sulfur Amino Acids With Brain Magnetic Resonance Imaging Measures in Older Adults: A Longitudinal Population-Based Study. (2016) (72)
Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. (2002) (71)
Apolipoprotein E ε4 and testosterone interact in the risk of Alzheimer's disease in men (2002) (70)
Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts. (2014) (69)
Aspiny neurons and their local axons in the neostriatum of the rat: a correlated light and electron microscopic study of Golgi-impregnated material (1984) (69)
Electron microscopic evidence of a monosynaptic pathway between cells in the caudal raphé nuclei and sympathetic preganglionic neurons in the rat spinal cord (2004) (67)
Essential fatty acids in membrane: physical properties and function. (1990) (67)
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. (2015) (67)
Predicting the time of conversion to MCI in the elderly (2009) (66)
The influence of electrical stimulation of certain brain regions on the concentration of acetylcholinesterase in rabbit cerebrospinal fluid (1979) (65)
Lysosomal phospholipases A1 and A2 of bovine adrenal medulla. (1968) (65)
Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. (1987) (64)
Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease (1991) (64)
Homocysteine, B vitamins, and cognitive deficit in the elderly. (2002) (64)
Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) (64)
DECREASED CSF ACETYLCHOLINESTERASE ACTIVITY IN ALZHEIMER'S DISEASE (1983) (63)
Monosynaptic innervation of trigeminal motor neurones involved in mastication by neurones of the parvicellular reticular formation (1993) (63)
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. (2012) (61)
Phytohaemagglutinin stimulation of human lymphocytes: effect of fatty acids on uridine uptake and phosphoglyceride fatty acid profile. (1977) (61)
Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer’s disease and to identify high-risk subgroups (2001) (61)
Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition (2020) (60)
Cysteine and Obesity (2012) (60)
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project (2012) (58)
Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease (2013) (58)
[39] Adrenal chromaffin granules: Isolation and disassembly (1974) (58)
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project (2010) (58)
Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum (2004) (57)
Homocysteine – from disease biomarker to disease prevention (2021) (57)
Effects of smoking on metabolism and excretion of vitamin B12. (1968) (57)
The effects of dietary (n-3) fatty acid supplementation on lipid dynamics and composition in rat lymphocytes and liver microsomes. (1986) (57)
Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease (2010) (56)
The Association of Plasma Cysteine and γ‐Glutamyltransferase With BMI and Obesity (2009) (55)
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid (2015) (55)
Secretion of proteins (chromogranin A and dopamine -hydroxylase) from a sympathetic neuron. (1971) (55)
Haemolysis of intact human erythrocytes by purified cobra venom phospholipase A2 in the presence of albumin and Ca2+. (1974) (55)
Convergence of synaptic terminals from the striatum and the globus pallidus onto single neurones in the substantia nigra and the entopeduncular nucleus. (1993) (55)
The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins. (2012) (54)
Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease (2009) (54)
Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease (2000) (53)
Iron genes, iron load and risk of Alzheimer’s disease (2006) (53)
Dietary cystine level affects metabolic rate and glycaemic control in adult mice☆☆☆ (2012) (53)
Neuropeptide Y-like immunoreactive structures in the rat stomach with special reference to the noradrenaline neuron system. (1985) (52)
Apolipoprotein E ε4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study (2006) (52)
Evidence for the presence of dopamine‐β‐hydroxylase in both populations of noradrenaline storage vesicles in sympathetic nerve terminals of the rat vas deferens (1973) (52)
Polymorphisms in the catechol‐O‐methyltransferase (COMT) gene influence plasma total homocysteine levels (2008) (51)
Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. (2012) (51)
Cognitive decline in the elderly after surgery and anaesthesia: results from the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort (2016) (49)
Blood Pressure, Dementia and Alzheimer’s Disease: The OPTIMA Longitudinal Study (2009) (49)
Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA (2015) (48)
Abnormal function of potassium channels in platelets of patients with Alzheimer's disease (1998) (47)
Uptake of [3H]taurine into medium-size neurons and into identified striatonigral neurons in the rat neostriatum (1983) (45)
Comparison of Pathological Diagnostic Criteria for Alzheimer Disease (1998) (45)
The diagnosis of Alzheimer's disease: a question of image? (1994) (44)
Haemolysis of washed human red cells by the combined action of Naja naja phospholipase A 2 and albumin. (1972) (43)
Cognitive Function in an Elderly Population: Interaction Between Vitamin B12 Status, Depression, and Apolipoprotein E [Latin Small Letter Open E]4: The Hordaland Homocysteine Study (2013) (42)
Linoleate metabolism in multiple sclerosis (1971) (42)
A multi-center study of ACE and the risk of late-onset Alzheimer's disease. (2011) (42)
Veganism: A Clinical Survey with Observations on Vitamin-B12 Metabolism (1962) (41)
Biochemical and morphological studies on catecholamine storage in human phaeochromocytoma. (1968) (40)
Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function. (2011) (40)
ABCA7 p.G215S as potential protective factor for Alzheimer's disease (2016) (38)
Characterization of pallidonigral neurons in the rat by a combination of Golgi impregnation and retrograde transport of horseradish peroxidase: their monosynaptic input from the neostriatum (1984) (38)
Sites of [3H]taurine Uptake in the Rat Substantia Nigra in Relation to the Release of Taurine from the Striatonigral Pathway (1990) (38)
Effect of fatty acid mixtures on phytohaemagglutinin-stimulated lymphocytes of different species. (1977) (38)
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study. (2019) (38)
The effect of chlorpromazine on the concentration of acetylcholinesterase in the cerebrospinal fluid of rabbits (1979) (38)
Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases (1998) (37)
The positional specificity of lysosomal phospholipase A activities. (1967) (37)
A simple and rapid method for the production of cholera B-chain coupled to horseradish peroxidase for neuronal tracing (1988) (37)
Association of the aromatase gene with Alzheimer's disease in women (2010) (37)
The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study (2019) (36)
Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease (2011) (36)
Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men (2003) (36)
Cerebral Subcortical Small Vessel Disease in Subjects With Pathologically Confirmed Alzheimer Disease: A Clinicopathologic Study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) (2014) (35)
Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study (2013) (35)
Genetic variation in homocysteine metabolism, cognition, and white matter lesions (2010) (35)
Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. (2007) (35)
The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project (2013) (34)
Gel electrophoresis of soluble and insoluble proteins of noradrenergic vesicles from ox splenic nerve: A comparison with proteins of adrenal chromaffin granules (1976) (33)
EARLY ANTENATAL DIAGNOSIS OF EXOMPHALOS (1980) (33)
Relationship between plasma and lymphocyte linoleate in multiple sclerosis. (1976) (33)
The experience of research participation and the value of diagnosis in dementia : Implications for practice (1998) (33)
High acceptability and low morbidity of diagnostic lumbar puncture in elderly subjects of mixed cognitive status (1995) (32)
Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3 (2018) (31)
Vitamin B-12 Status during Pregnancy and Child’s IQ at Age 8: A Mendelian Randomization Study in the Avon Longitudinal Study of Parents and Children (2012) (30)
Ultrastructural studies on the adrenal medulla of golden hamster: Origin and fate of secretory granules (2004) (30)
Association of Methionine to Homocysteine Status With Brain Magnetic Resonance Imaging Measures and Risk of Dementia. (2019) (30)
Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease (2013) (29)
Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats (2005) (29)
Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: Implications for neurodegenerative disorders (2008) (29)
Intracellular localization of acetylcholinesterase in nerve terminals and capillaries of the rat superior cervical ganglion (1978) (29)
Homocysteine, B vitamins, and cardiovascular disease. (2006) (29)
Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease (2018) (28)
Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm (2000) (28)
Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. (2002) (28)
Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis. (1980) (28)
Monosynaptic innervation of facial motoneurones by neurones of the parvicellular reticular formation (2004) (27)
Letter: Linoleic acid as an immunosuppressive agent. (1975) (26)
Catecholamines in phaeochromocytoma. Normal storage but abnormal release? (1968) (26)
Are we ready for mandatory fortification with vitamin B-12? (2008) (26)
HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease (2001) (26)
Cysteine, homocysteine and bone mineral density: a role for body composition? (2009) (26)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
Synaptic connections of axo-axonic (chandelier) cells in human epileptic temporal cortex (1986) (25)
An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A. (1979) (25)
The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer’s Disease in a Population of European Descent (2015) (25)
Some properties of soluble proteins from chromaffin granules of different species. (1968) (24)
Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study (2011) (24)
BIOCHEMICAL STUDIES OF THE MECHANISM OF RELEASE (1979) (24)
Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse. (2002) (24)
The interaction of serum folate and estradiol levels in Alzheimer's disease. (2002) (23)
Acid phospholipase A in lysosomes of the bovine adrenal medulla. (1967) (23)
Acetylcholinesterase Activity in Regions of the Rat Brain Following a Convulsion (1986) (23)
Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. (2012) (23)
Association between subcortical vascular disease on CT and neuropathological findings (2004) (22)
Hyperhomocysteinaemia in Alzheimer's disease and expression of cell cycle markers in the brain (2000) (22)
Associations of Folate, Vitamin B12, Homocysteine, and Folate-Pathway Polymorphisms with Prostate-Specific Antigen Velocity in Men with Localized Prostate Cancer (2010) (22)
Synaptic connections of substance P-immunoreactive nerve terminals in the substantia nigra of the rat (1982) (22)
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. (1985) (22)
Spontaneous and carbachol-evoked in vivo secretion of acetylcholinesterase from the hippocampus of the rat (1987) (21)
Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array (2017) (21)
Wallerian degeneration of rat sciatic nerve. Changes in cholesteryl ester content and fatty acid composition (1976) (20)
Why are drug trials in Alzheimer's disease failing? (2010) (20)
Apolipoprotein E ε2 may be a risk factor for sporadic frontotemporal dementia (2000) (20)
Factors influencing the cholinesterases of cerebrospinal fluid in the anaesthetized cat (1984) (20)
Homocysteine lowering, B vitamins, and cognitive aging. (2015) (20)
SERUM LIPIDS IN TREATED DIABETIC CHILDREN AND THEIR FAMILIES (1978) (19)
Phaeochromocytoma and Other Catecholamine-Producing Tumours (1972) (19)
Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid. (2014) (19)
Autopsy: consent, completion and communication in Alzheimer's disease research. (1993) (19)
Leukoaraiosis at Presentation and Disease Progression during Follow‐up in Histologically Confirmed Cases of Dementia (2000) (19)
The CT‐based radial width of the temporal horn: pathological validation in AD without cerebrovascular disease (2004) (19)
Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project (2012) (19)
The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer's disease in men. (2004) (19)
N‐homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia (2019) (18)
PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients (2009) (18)
No evidence that extended tracts of homozygosity are associated with Alzheimer's disease (2011) (18)
Relationships between catecholaminergic neurons and cholecystokinin-containing neurons in the caudal part of the dorsomedial medulla oblongata of the rat: light and electron microscopic observations by the ‘mirror technique’ (1986) (18)
Structural and functional bases of visuospatial associative memory in older adults (2013) (18)
Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? (2006) (17)
Membrane lipid modification and immune function (1985) (17)
The effect of fatty acids and of albumin on the action of a purified phospholipase A 2 from cobra venom on synthetic lecithins. (1972) (17)
Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease (2016) (16)
Adrenal chromaffin granules: isolation and disassembly. (1974) (16)
Proceedings: Increased concentration of an isoenzyme of acetylcholinesterase in rabbit cerebrospinal fluid after peripheral stimulation. (1974) (16)
The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers? (2011) (15)
Decision on folic acid fortification in Europe must consider both risks and benefits (2016) (15)
Medial Temporal Lobe Atrophy, Apolipoprotein Genotype, and Plasma Homocysteine in Sri Lankan Patients with Alzheimer's Disease (2005) (15)
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease (2011) (14)
Pathological Validation of a CT-Based Scale for Subcortical Vascular Disease (2005) (14)
Bradykinin stimulates DNA synthesis in competent Balb/c 3T3 cells and enhances inositol phosphate formation induced by platelet-derived growth factor. (1991) (14)
Dopamine beta-hydroxylase release during hypertension from sympathetic nervous overactivity in man. (1976) (13)
Folic acid nutrition: what about the little children? (2010) (13)
Is acetylcholinesterase secreted from central neurons into the cerebral fluid? (1976) (13)
Placental exchange area in guinea pigs following long-term maternal exercise: a stereological analysis. (1983) (13)
Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease (2006) (13)
Dementia Prevention by Disease-Modification through Nutrition. (2017) (13)
A neuroleptic-like effect of ceronapril on latent inhibition (1992) (13)
Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults (2019) (13)
Uptake, localization and release of taurine in the rat basal ganglia. (1987) (13)
The sigma ligand BMY‐14802 as a potential antipsychotic: evidence from the latent inhibition model in rats (1995) (12)
B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true? (2016) (12)
Inhibition of complement-dependent rosette formation after lymphocyte incubation with fatty acids. (1979) (12)
Evaluation of (−)-epicatechin metabolites as recovery biomarker of dietary flavan-3-ol intake (2019) (12)
A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD (2008) (12)
Mechanism of secretion from the adrenal medulla (2004) (12)
Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients (2008) (11)
The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk. (2019) (11)
GABA-like immunoreactivity in different cellular populations of cerebellar cortex of rats before and after treatment with amino-oxyacetic acid (1991) (11)
Response to platelet‐activating factor of platelets from patients with multiple sclerosis (1985) (11)
AMNIOTIC-FLUID ACETYLCHOLINESTERASE AND NEURAL-TUBE DEFECTS: PLEA FOR STANDARDISATION (1979) (11)
The storage of hormones. (1968) (10)
Levels of polyunsaturated fatty acids in lymphocytes of rats fed on diets varying in polyunsaturated fatty acid content (1980) (10)
Accumulation of diacylglycerol induced in platelets by exogenous fatty acids. (1980) (10)
Prevention of Dementia: A Role for B Vitamins? (2006) (10)
Diagnosis of Alzheimer's disease. (1991) (10)
Hippocampus as a mediator of the role of vitamin B-12 in memory. (2016) (9)
Modulation of membrane protein function by bilayer lipids. (1987) (9)
The impact of early life factors on cognitive function in old age: The Hordaland Health Study (HUSK) (2013) (9)
The effects of chronic administration of ceronapril on the partial reinforcement extinction effect and latent inhibition in rats (1994) (9)
Unsaturated fatty acids stimulate the formation of lipoxygenase and cyclooxygenase products in rat spleen lymphocytes. (1984) (9)
Interaction of nutrition and genetics via DNMT3L-mediated DNA methylation determines cognitive decline (2019) (8)
FETAL CALF SERUM AS CAUSE OF FALSE POSITIVE AMNIOTIC FLUID ACETYLCHOLINESTERASE GEL TESTS (1982) (8)
Anti‐N‐homocysteine‐protein autoantibodies are associated with impaired cognition (2021) (7)
Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors (2021) (7)
Separation of multiple molecular forms of acetylcholinesterase by using affinity chromatography: isolation of the 'secretory' form [proceedings]. (1978) (7)
Effectiveness of B Vitamins and Their Interactions with Aspirin in Improving Cognitive Functioning in Older People with Mild Cognitive Impairment: Pooled Post-Hoc Analyses of Two Randomized Trials (2021) (7)
Hemolysis of washed human red cells by various snake venoms in the presence of albumin and Ca2+. (1974) (7)
Formation of diacylglycerol and degradation of phosphatidylinositol induced in rat lymphocytes by non-esterified oleic or linoleic acid. (1983) (7)
Association of Homocysteine, Methionine, and MTHFR 677C>T Polymorphism With Rate of Cardiovascular Multimorbidity Development in Older Adults in Sweden (2020) (7)
Deafferentation of the hippocampus results in the induction of AT8 positive ‘granules’ in the rat (2001) (6)
Cellular control of the uptake, storage and release of noradrenaline in sympathetic nerves. (1972) (6)
Ruthenium red staining of the hamster adrenal medulla (2004) (6)
Release of dopamine beta-hydroxylase during sympathetic nervous activity in tetraplegic man. (1975) (5)
B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment (2021) (5)
ω-3 fatty acids and their interactions. (2021) (5)
Effect of short-term oral administration of sunflower seed oil on the pattern of non-esterified fatty acids in human plasma. (1975) (5)
Lipids of adrenal chromaffin granules: Fatty acid composition of phospholipids, in particular lysolecithin (2004) (5)
Growth of central substance P-containing neurons into superior cervical ganglia transplanted in the spinal cord of adult rats (1984) (5)
H.p.l.c. analysis of inositol monophosphate isomers formed on angiotensin II stimulation of rat adrenal glomerulosa cells. (1987) (5)
Release of chromogranin A and dopamine-beta-hydroxylase from adrenergic nerves during nerve stimulation. (1970) (5)
A cytochemical study of the calcium-activated adenosinetriphosphatase in hamster adrenal medulla: its occurrence in the golgi region of chromaffin cells (2004) (5)
Idiopathic acute transverse myelitis : Application of the recent diagnostic criteria. Author's reply (2006) (5)
Signal transduction in rat adrenal fasciculata cells stimulated by ACTH1-39 and ACTH5-24: role of the phosphoinositide response in steroidogenesis. (1990) (5)
Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome (2017) (4)
Modifiable risk factors for incident dementia and cognitive impairment: An umbrella review of evidence. (2021) (4)
FATTY ACID PATTERNS OF RED BLOOD CELL PHOSPHOLIPIDS IN PATIENTS WITH MULTIPLE SCLEROSIS (1981) (4)
Oxford Project to Investigate Memory and Ageing (OPTIMA): A Longitudinal Clinicopathological Study of Dementia and Normal Ageing (2002) (4)
Ultrastructural studies on the formation and release of secretory material in the adrenal medulla of the golden hamster. (1971) (4)
Verapamil inhibits phosphatidic acid formation and modifies phosphoinositide metabolism in stimulated platelets. (1990) (3)
Specific antibodies to bovine choline acetyltransferase raised in mice immunised with small amounts of partially purified enzyme (1982) (3)
The demonstration of lysosomes in the bovine adrenal medulla (1966) (3)
Presynaptic dopaminergic properties of differentiated mouse embryonic stem cells (2004) (3)
Degeneration of serotonin-specific neurons in the brain in experimental Trypanosoma brucei infection. (1988) (3)
Association study of MICA and MICB in Alzheimer's disease. (2009) (3)
Extracellular release of lysosomal phospholipases from the perfused adrenal gland. (1969) (3)
The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials (2021) (3)
Acetylcholinesterases in perfusates of the cat's cerebral ventricles [proceedings]. (1976) (3)
Anti-amyloid trials raise scientific and ethical questions (2021) (3)
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here? (2021) (3)
Membrane-bound enzymes in adrenal medulla: an adenosine triphosphatase characteristic of the Golgi apparatus. (1971) (3)
Irish Neurological Association Proceedings of the 23rd Annual Scientific Meeting of the Irish Neurological Association — Galway, 9th–10th October 1987 (1988) (2)
Omega-3 Supplementation for the Prevention of Cognitive Decline in Older Adults: Does It Depend on Homocysteine Levels? (2022) (2)
Effect in rat lymphocytes of fatty acids and concanavalin A on the fluorescence polarization of 1,6-diphenylhexatriene [proceedings]. (1978) (2)
The Effects of Omega-3 Fatty Acids in Multiple Sclerosis: 2-Year-Results (1989) (2)
Demonstration of monosynaptic input to identified efferent neurones in the basal ganglia by a new morphological procedure [proceedings]. (1979) (2)
Proceedings: Changes in acetylcholinesterase concentration in rabbit cerebrospinal fluid following central electrical stimulation. (1976) (2)
An unusual Ca(2+) entry pathway activated by protein kinase C in dog splenic artery. (1999) (2)
Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2011) (2)
Subcellular fractionation of bovine splenic nerves. (1969) (2)
Role of phosphoinositol metabolism and phospholipases C and A2/A1 in signal transduction in isolated rat adrenal cells. (1989) (2)
Folic Acid for the Prevention of Neural Tube Defects. (2017) (2)
Plasma alkaline phosphatase inversely correlates with cognitive function in Alzheimer's disease (2010) (1)
Proceedings: Cytochemical studies on pre- and post-synaptic acetylcholinesterase in the bovine adrenal gland. (1974) (1)
The importance of vitamin B12 for individuals choosing plant-based diets (2022) (1)
The release of acetylcholinesterase into rabbit cerebrospinal fluid on cooling the substantia nigra and caudate nucleus [proceedings]. (1977) (1)
Lysosomal Phospholipases A 1 and A 2 of Bovine Adrenal Medulla (2005) (1)
Radiological detection of proven Alzheimer’s disease during life using CT evidence of minimum medial temporal lobe thickness (1995) (1)
Reply to E Baggott and SL Morgan (2008) (1)
Evidence-based prevention and treatment of dementia (2016) (1)
Dietary Supplements for Brain Health. (2019) (1)
Proceedings: Release of an isoenzyme of acetylcholinesterase from the perfused adrenal gland. (1974) (1)
Subcellular localization of acetylcholine in Auerbach's plexus. (1971) (1)
451 SPET (99mTc-HMPAO) and X-ray CT in the diagnosis of Alzheimer's disease: Improved accuracy over clinical criteria in a cohort of 114 prospectively evaluated subjects with histopathological diagnoses (1996) (1)
P3-092: Prediction of short-term and long-term cognitive decline in moderate Alzheimer's disease patients in the Oxford project to investigate memory and aging (optima) cohort using CSF biomarkers (2008) (1)
Cellular control of the uptake, storage and release of catecholamines. (1972) (1)
Performance on the HVLT by MCI participants is modulated by baseline plasma homocysteine levels, in a 2 year randomised trial of B vitamins (vitacog) (2010) (1)
Studies on blood from patients with dominantly-inherited retinitis pigmentosa. (1989) (1)
74 Disease-modification in mild cognitive impairment by lowering homocysteine (2012) (1)
Desaggregation by Verapamil, Sodium Nitroprusside and PGE(1), of Rabbit Platelets Aggregated by PAF-acether. A Morphological and Biochemical Study. (1993) (1)
Two nutrients are better than one: B-vitamins and omega-3 fatty acids in the prevention of dementia (2017) (0)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
Combined CT scan and SPET scan measures significantly increase diagnostic accuracy of Alzheimer's disease in life.: A study with post mortem confirmation (1992) (0)
Combined CT scan and SPET scan measures significantly increase diagnostic accuracy of Alzheimer's disease in life.: A study with post mortem confirmation (1992) (0)
P4-048: Pulse pressure, dementia and Alzheimer's disease: The Oxford Project to Investigate Memory and Ageing (OPTIMA) Longitudinal Study (2008) (0)
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
In Vivo Monitoring of Neurotransmitters with Voltammetry and Smallbore HPLC (1994) (0)
University of Birmingham Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease (2013) (0)
Concordant association of functional IDE variant with IDE mRNA, Aß, and Alzheimer's disease (2009) (0)
The soluble transcobalamin receptor (sCD320) in relation to Alzheimer’s disease and cognitive scores (2017) (0)
P1-157: TICS-m and cantab PAL: The ideal telephone screen and memory test for selecting amnestic mild cognitive impairment cases for clinical trials: The oxford project to investigate memory and ageing (optima) vitacog trial experience (2008) (0)
Increase of acetylcholinesterase activity of the cerebrospinal fluid of the rabbit after sciatic nerve stimulation. Its blockade by atropine. (1985) (0)
The effect of fatty acids and albumin on the transformation of rodent spleen lymphocytes stimulated by phytohaemagglutinin, concanavalin A or bacterial lipopolysaccharide [proceedings]. (1977) (0)
Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease (2013) (0)
The metabolism of a high intake of nicotinamide in choline deficeint rats (1987) (0)
P2-165 A multi-analyte panel of six CSF biomarkers classifies AD and control in pathologically confirmed Alzheimer subjects within the OPTIMA cohort (2006) (0)
A multi-centre study of ACE and the risk of late-onset Alzheimer ’ s disease (2013) (0)
Association of life course adiposity with risk of incident dementia: a prospective cohort study of 322,336 participants (2022) (0)
A simple way of measuring the progression of confirmed Alzheimer's disease in the brain by serial temporal-lobe-oriented CT scans (1997) (0)
Methylation status and sulfur amino acids as risk factors for cognitive decline over 15 years: A longitudinal, population‐based study (2020) (0)
Reply to RJ Berry et al (2007) (0)
Species-dependent effects of adenosine receptor agonists on contractile responses of vas deferens to ATP. (1999) (0)
Maternal and infant vitamin B12 status and development (2018) (0)
ociations of Folate , Vitamin B 12 , Homocysteine , and te-Pathway Polymorphisms with Prostate-Specific B & P igen Velocity in Men with Localized Prostate Cancer (2010) (0)
Modulation of (35S)TBPS binding to GABAA receptors in mouse brain (2003) (0)
The impact of early life factors on cognitive function in old age: The Hordaland Health Study (HUSK) (2013) (0)
Alzheimer ' s disease . clinical and pathological diagnosis of parietotemporal cortex in patients with a lobe with reduced blood flow in the posterior Association of atrophy of the medial temporal (2004) (0)
Alzheimer ' s disease . clinical and pathological diagnosis of parietotemporal cortex in patients with a lobe with reduced blood flow in the posterior Association of atrophy of the medial temporal (2004) (0)
Measuring Persistent Organic Pollutants (PBDES) in River Otter Scat (2017) (0)
A possible ante mortem diagnostic test for Alzheimer's disease (1992) (0)
Explorer Concordant Association of Insulin Degrading Enzyme Gene ( IDE ) Variants with IDE mRNA , A beta , and Alzheimer ' s Disease (2017) (0)
The structural and functional neuroanatomy of successful visuospatial learning in normal aging (2010) (0)
P2-153 The CT-based radial width of the temporal horn: pathological validation in AD (2004) (0)
Original Article The causal roles of vitamin B12 and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers? (2011) (0)
Apolipoprotein E fragmentation in human brain and CSF samples is isoform and Alzheimer's disease dependent (2009) (0)
P2-238 Plasma homocysteine level is predictive of later cognitive impairment and brain volume decrease in community-dwelling older adults (2006) (0)
P3-201: Polymorphisms in four candidate genes for sporadic Alzheimer's disease are associated with altered rate and age of cognitive decline (2008) (0)
Catecholamine transport systems (1976) (0)
8 Acetylcholinesterase in cerebrospinal fluid in relation to histopathological diagnosis of Alzheimer's disease and apolipoprotein E allelotype (1996) (0)
5 th Amino Acid Assessment Workshop The Hordaland Homocysteine Study : A Community-Based Study of Homocysteine , Its Determinants , and Associations with Disease 1 (2006) (0)
Mobilization of hypothalamus acetylcholinesterase from bound to soluble fraction by electrical stimulation of the rabbit sciatic nerve. (1985) (0)
An Approach to the Identification of Neurotra in Syna of Complex Neuron Networks : Application to the (0)
Vitamin B-12 and cognition in the elderly 1 – 4 (2009) (0)
An update on folic acid fortification: benefits and risks 2012 (2012) (0)
[Peripheral noradrenergic neurosecretion]. (1971) (0)
P1-205 Folate levels and cognitive performance. The Rotterdam Scan Study (2006) (0)
CATECHOLAMINES IN PHÆOCHROMOCYTOMA (1968) (0)
O R I G I N A L A R T I C L E The Interaction of Serum Folate and Estradiol Levels in Alzheimer's Disease (2002) (0)
Lung function and risk of incident dementia: A prospective cohort study of 431,834 individuals (2023) (0)
STABILITY OF SERUM OLEATE AND LINOLEATE LEVELS AFTER ORAL ADMINISTRATION OF OLEIC ACID (1975) (0)
Towards the prevention of Alzheimer's disease: Dietary risk factors as targets for prevention (1998) (0)
Soluble Transcobalamin Receptor in Relation to Alzheimer’s disease and Cognitive Scores (2018) (0)
To determine whether supplementation with B vitamins that lower levels of plasma total homocysteine can slow the rate of brain atrophy in subjects with mild cognitive impairment in a randomised controlled trial (VITACOG, ISRCTN 94410159). (2015) (0)
Measurament of GABA immunoreactivity in different neuronal populations of cerebellar cortex of rats before and after treatment with amino-oxyacetic acid (AOAA) (1988) (0)
Hippocampal atrophy in Alzheimer disease: Age matters (2006) (0)
Dis aggregation by different drugs of platelets aggregated by platelet activating factor (1983) (0)
P4-097: Previous and concurrent blood pressure and cognitive function in dementia and Alzheimer's disease: The Oxford Project to Investigate Memory and Ageing (OPTIMA) Longitudinal Study (2008) (0)
VITAMIN B12, FOLATE, AND SULFUR AMINO-ACIDS AS RISK FACTORS FOR DEMENTIA AND COGNITIVE DECLINE: A LONGITUDINAL POPULATION-BASED STUDY (2017) (0)
Significant reduction of grey matter loss with vitamin B treatment in cognitively impaired elderly (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David Smith?

David Smith is affiliated with the following schools: